Page last updated: 2024-10-23

aspirin and Carcinoma, Anaplastic

aspirin has been researched along with Carcinoma, Anaplastic in 45 studies

Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.

Research Excerpts

ExcerptRelevanceReference
"Although aspirin is recommended for the prevention of colorectal cancer, the specific individuals for whom the benefits outweigh the risks are not clearly defined."9.24ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial. ( Backman, V; Carolan, PJ; Chan, AT; Chin, SM; Chung, DC; Colizzo, FP; Drew, DA; Flagg, M; Freedman, M; Gala, M; Garber, JJ; Gilpin, KK; Huttenhower, C; Kedrin, D; Khalili, H; Kwon, DS; Markowitz, SD; Milne, GL; Nishioka, NS; Parziale, M; Pond, E; Rawlings, CA; Richter, JM; Roy, HK; Schuck, MM; Staller, K; Stewart, K; Wang, M, 2017)
"To assess the efficacy of fertility-sparing treatment using medroxyprogesterone acetate (MPA) for endometrial carcinoma (EC) and atypical endometrial hyperplasia (AH) in young women."9.12Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. ( Fukunaga, M; Hatae, M; Hiura, M; Iwasaka, T; Kamura, T; Kodama, S; Konishi, I; Nakanishi, T; Saito, T; Saji, F; Sakamoto, A; Sasaki, H; Terakawa, N; Tsuda, H; Ushijima, K; Yaegashi, N; Yahata, H; Yasugi, T; Yoshikawa, H, 2007)
"Aspirin was administered at a dose of 81 mg once daily for 28 days in a cohort of 92 matched high-risk and normal-risk colorectal cancer subjects."9.09Colonic mucosal prostaglandin E2 and cyclooxygenase expression before and after low aspirin doses in subjects at high risk or at normal risk for colorectal cancer. ( Bailey, J; Boland, CR; Brenner, DE; Burney, K; Krishnan, K; Normolle, D; Peters-Golden, M; Rock, CL; Ruffin, MT; Shureiqi, I, 2001)
"In this study, we observed that low-dose aspirin use was associated with a lower risk of lung carcinoma and lung carcinoma-related mortality among COPD patients."8.12Low-dose aspirin and incidence of lung carcinoma in patients with chronic obstructive pulmonary disease in Hong Kong: A cohort study. ( Cheung, KS; Ip, MS; Li, HL; Li, X; Ren, QW; Tse, HF; Wong, PF; Wu, MZ; Yiu, KH; Yu, SY, 2022)
" We aimed to examine aspirin use on cancer-specific survival in various BTC subtypes, including gallbladder cancer, ampulla of Vater cancer, and cholangiocarcinoma."8.02Postdiagnosis Aspirin Use Associated With Decreased Biliary Tract Cancer-Specific Mortality in a Large Nationwide Cohort. ( Chan, C; Chen, CJ; Chen, YJ; Hsieh, RJ; Huang, C; Huang, CP; Huang, YH; Jackson, SS; Koshiol, J; Lee, MH; Liao, SF; Liu, PC; Lu, SN; Shen, CY, 2021)
"Aspirin is associated with a reduced risk of developing colorectal cancer."7.79Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality. ( Donnan, PT; McCowan, C; Munro, AJ; Steele, RJ, 2013)
"Regular aspirin intake is associated with a reduction in the incidence of colorectal cancer."7.76Aspirin and alterations in DNA repair proteins in the SW480 colorectal cancer cell line. ( Brown, JE; Dibra, HK; Hooley, P; Nicholl, ID, 2010)
"Regular aspirin intake may reduce the risk of colorectal cancer by 50%."7.69Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma relative to adenoma cell lines. ( Elder, DJ; Hague, A; Hicks, DJ; Paraskeva, C, 1996)
"Nine trials with 150 familial adenomatous polyposis (FAP) and 24,143 population subjects met the inclusion criteria."6.42Non steroidal anti-inflammatory drugs (NSAID) and Aspirin for preventing colorectal adenomas and carcinomas. ( Asano, TK; McLeod, RS, 2004)
"A total of 5308 patients with type 2 diabetes were identified by the National Health Insurance from 1998 to 2000 and followed up until 2013."5.72Antiplatelet agents aspirin and dipyridamole, and the risk of different carcinoma in patients with type 2 diabetes mellitus: A Taiwan retrospective cohort study. ( Hsu, WH; Huang, HY; Lee, MY; Liang, HL; Lu, TW; Sung, YW, 2022)
"Although aspirin is recommended for the prevention of colorectal cancer, the specific individuals for whom the benefits outweigh the risks are not clearly defined."5.24ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial. ( Backman, V; Carolan, PJ; Chan, AT; Chin, SM; Chung, DC; Colizzo, FP; Drew, DA; Flagg, M; Freedman, M; Gala, M; Garber, JJ; Gilpin, KK; Huttenhower, C; Kedrin, D; Khalili, H; Kwon, DS; Markowitz, SD; Milne, GL; Nishioka, NS; Parziale, M; Pond, E; Rawlings, CA; Richter, JM; Roy, HK; Schuck, MM; Staller, K; Stewart, K; Wang, M, 2017)
"In a randomized, placebo-controlled trial, we used a two-by-two design to investigate the effects of aspirin, at a dose of 600 mg per day, and resistant starch (Novelose), at a dose of 30 g per day, in reducing the risk of adenoma and carcinoma among persons with the Lynch syndrome."5.13Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. ( Barker, G; Bertario, L; Bisgaard, ML; Bishop, DT; Burn, J; Dunlop, M; Eccles, D; Elliott, F; Evans, DG; Fodde, R; Ho, JW; Jarvinen, HJ; Jass, JR; Lindblom, A; Lubinski, J; Lynch, HT; Macrae, F; Maher, ER; Mathers, JC; Mecklin, JP; Morrison, PJ; Möslein, G; Olschwang, S; Ramesar, R; Scott, RJ; Side, L; Thomas, HJ; Vasen, HF, 2008)
"To assess the efficacy of fertility-sparing treatment using medroxyprogesterone acetate (MPA) for endometrial carcinoma (EC) and atypical endometrial hyperplasia (AH) in young women."5.12Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. ( Fukunaga, M; Hatae, M; Hiura, M; Iwasaka, T; Kamura, T; Kodama, S; Konishi, I; Nakanishi, T; Saito, T; Saji, F; Sakamoto, A; Sasaki, H; Terakawa, N; Tsuda, H; Ushijima, K; Yaegashi, N; Yahata, H; Yasugi, T; Yoshikawa, H, 2007)
"Aspirin was administered at a dose of 81 mg once daily for 28 days in a cohort of 92 matched high-risk and normal-risk colorectal cancer subjects."5.09Colonic mucosal prostaglandin E2 and cyclooxygenase expression before and after low aspirin doses in subjects at high risk or at normal risk for colorectal cancer. ( Bailey, J; Boland, CR; Brenner, DE; Burney, K; Krishnan, K; Normolle, D; Peters-Golden, M; Rock, CL; Ruffin, MT; Shureiqi, I, 2001)
" Baseline or on-study aspirin use was associated with modest increases in grade 3 and 4 bleeding events in both treatment groups, from 3."4.84Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. ( Bergsland, E; Gerber, HP; Holden, SN; Holmgren, E; Hurwitz, H; Kabbinavar, F; Miller, K; Ngai, J; Scappaticci, FA; Skillings, JR; Wang, J, 2007)
"In this study, we observed that low-dose aspirin use was associated with a lower risk of lung carcinoma and lung carcinoma-related mortality among COPD patients."4.12Low-dose aspirin and incidence of lung carcinoma in patients with chronic obstructive pulmonary disease in Hong Kong: A cohort study. ( Cheung, KS; Ip, MS; Li, HL; Li, X; Ren, QW; Tse, HF; Wong, PF; Wu, MZ; Yiu, KH; Yu, SY, 2022)
" We aimed to examine aspirin use on cancer-specific survival in various BTC subtypes, including gallbladder cancer, ampulla of Vater cancer, and cholangiocarcinoma."4.02Postdiagnosis Aspirin Use Associated With Decreased Biliary Tract Cancer-Specific Mortality in a Large Nationwide Cohort. ( Chan, C; Chen, CJ; Chen, YJ; Hsieh, RJ; Huang, C; Huang, CP; Huang, YH; Jackson, SS; Koshiol, J; Lee, MH; Liao, SF; Liu, PC; Lu, SN; Shen, CY, 2021)
"Regular aspirin use has been associated to decreased risk of several cancers, but evidence on nasopharyngeal carcinoma is scanty."3.81Regular aspirin use and nasopharyngeal cancer risk: A case-control study in Italy. ( Bosetti, C; Di Maso, M; Garavello, W; La Vecchia, C; Libra, M; Montella, M; Polesel, J; Serraino, D, 2015)
"Aspirin is associated with a reduced risk of developing colorectal cancer."3.79Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality. ( Donnan, PT; McCowan, C; Munro, AJ; Steele, RJ, 2013)
"Regular aspirin intake is associated with a reduction in the incidence of colorectal cancer."3.76Aspirin and alterations in DNA repair proteins in the SW480 colorectal cancer cell line. ( Brown, JE; Dibra, HK; Hooley, P; Nicholl, ID, 2010)
"The association between lung carcinoma risk and regular use of NSAIDs, including aspirin, was evaluated in a hospital-based case-control study of 1038 patients and 1002 controls."3.72Risk of lung carcinoma among users of nonsteroidal antiinflammatory drugs. ( Altorki, NK; Chen, SQ; Citron, M; Muscat, JE; Neugut, AI; Olson, S; Richie, JP; Stellman, SD, 2003)
"Regular aspirin intake may reduce the risk of colorectal cancer by 50%."3.69Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma relative to adenoma cell lines. ( Elder, DJ; Hague, A; Hicks, DJ; Paraskeva, C, 1996)
" There is substantial evidence that N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide (FANFT) is deformylated to 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT) in the process of FANFT-induced bladder cancer."3.67Role of renal metabolism and excretion in 5-nitrofuran-induced uroepithelial cancer in the rat. ( Cohen, SM; Davis, BB; Spry, LA; Zenser, TV, 1985)
" The effects of warfarin, aspirin and heparin administration on the early arrest patterns of 125IdUrd-labelled TA3 carcinoma and Gardner lymphosarcoma cells injected intravenously into tumor-bearing mice were examined."3.66Initial tumor cell arrest in animals of defined coagulative status. ( Glaves, D; Weiss, L, 1978)
"Lynch syndrome is an autosomal-dominant hereditary cancer syndrome."2.55Approach to Lynch Syndrome for the Gastroenterologist. ( Bui, QM; Ho, W; Lin, D, 2017)
"Nine trials with 150 familial adenomatous polyposis (FAP) and 24,143 population subjects met the inclusion criteria."2.42Non steroidal anti-inflammatory drugs (NSAID) and Aspirin for preventing colorectal adenomas and carcinomas. ( Asano, TK; McLeod, RS, 2004)
"A total of 5308 patients with type 2 diabetes were identified by the National Health Insurance from 1998 to 2000 and followed up until 2013."1.72Antiplatelet agents aspirin and dipyridamole, and the risk of different carcinoma in patients with type 2 diabetes mellitus: A Taiwan retrospective cohort study. ( Hsu, WH; Huang, HY; Lee, MY; Liang, HL; Lu, TW; Sung, YW, 2022)
"Risk models for advanced colorectal neoplasms generally yielded modest discriminatory power, despite some variation in performance between models."1.51Head-to-Head Comparison of the Performance of 17 Risk Models for Predicting Presence of Advanced Neoplasms in Colorectal Cancer Screening. ( Balavarca, Y; Brenner, H; Hoffmeister, M; Peng, L; Weigl, K, 2019)
"Previous studies have suggested that migraineurs are at decreased risk for developing breast cancer."1.39Migraine and subsequent risk of breast cancer: a prospective cohort study. ( Buring, JE; Kurth, T; Lee, IM; Rexrode, KM; Tamimi, RM; Winter, AC, 2013)
"The risk of postoperative hemorrhage following gastric ESD was higher in patients with antithrombotic therapy than in those without that therapy."1.39The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection. ( Edogawa, S; Harada, S; Higuchi, K; Kojima, Y; Ota, K; Takeuchi, T; Tokioka, S; Umegaki, E, 2013)
"In support of this, the breast cancer cell line MCF-7 stimulated secretion of VEGF and a pro-angiogenic releasate from platelets."1.37Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis. ( Battinelli, EM; Italiano, JE; Markens, BA, 2011)
" We investigated the long-term administration of low dose of aspirin in a model of experimental colon carcinogenesis in rats."1.36Long-term administration of aspirin inhibits tumour formation and triggers anti-neoplastic molecular changes in a pre-clinical model of colon carcinogenesis. ( Bouhadjar, M; Bousserouel, S; Gosse, F; Marescaux, J; Raul, F; Soler, L, 2010)
"Diclofenac was COX-1/2 non-selective when tested in vitro, but a slightly preferential inhibitor of COX-2 when tested ex vivo."1.30Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs. ( Giuliano, F; Warner, TD, 1999)

Research

Studies (45)

TimeframeStudies, this research(%)All Research%
pre-19907 (15.56)18.7374
1990's3 (6.67)18.2507
2000's11 (24.44)29.6817
2010's19 (42.22)24.3611
2020's5 (11.11)2.80

Authors

AuthorsStudies
Yu, SY1
Ip, MS1
Li, X1
Cheung, KS1
Ren, QW1
Wu, MZ1
Li, HL1
Wong, PF1
Tse, HF1
Yiu, KH1
Zaccari, P1
Archibugi, L1
Belfiori, G1
Nista, E1
dell'Anna, G1
Crippa, S1
Schepis, T1
Tacelli, M1
Aleotti, F1
Petrone, MC1
Mariani, A1
Costamagna, G1
Gasbarrini, A1
Larghi, A1
Falconi, M1
Arcidiacono, PG1
Capurso, G1
Huang, HY1
Lu, TW1
Liang, HL1
Hsu, WH1
Sung, YW1
Lee, MY1
Peng, L1
Balavarca, Y1
Weigl, K1
Hoffmeister, M1
Brenner, H1
Liao, SF1
Koshiol, J1
Huang, YH2
Jackson, SS1
Chan, C1
Huang, C1
Liu, PC1
Chen, YJ1
Hsieh, RJ1
Huang, CP1
Lu, SN1
Chen, CJ1
Shen, CY1
Lee, MH1
Kamal, H1
Sadr-Azodi, O1
Engstrand, L1
Brusselaers, N1
Sahin, IH1
McCowan, C2
Donnan, PT2
Munro, AJ2
Steele, RJ2
Takeuchi, T1
Ota, K1
Harada, S1
Edogawa, S1
Kojima, Y1
Tokioka, S1
Umegaki, E1
Higuchi, K1
Di Maso, M1
Bosetti, C1
La Vecchia, C1
Garavello, W1
Montella, M1
Libra, M1
Serraino, D1
Polesel, J1
Sanin, V1
Pfetsch, V1
Koenig, W1
Bui, QM1
Lin, D1
Ho, W1
Drew, DA1
Chin, SM1
Gilpin, KK1
Parziale, M1
Pond, E1
Schuck, MM1
Stewart, K1
Flagg, M1
Rawlings, CA1
Backman, V1
Carolan, PJ1
Chung, DC1
Colizzo, FP1
Freedman, M1
Gala, M1
Garber, JJ1
Huttenhower, C1
Kedrin, D1
Khalili, H1
Kwon, DS1
Markowitz, SD1
Milne, GL1
Nishioka, NS1
Richter, JM1
Roy, HK1
Staller, K1
Wang, M1
Chan, AT1
Parmar, HS1
Houdek, Z1
Pesta, M1
Vaclava, C1
Dvorak, P1
Hatina, J1
Burn, J1
Bishop, DT1
Mecklin, JP1
Macrae, F1
Möslein, G1
Olschwang, S1
Bisgaard, ML1
Ramesar, R1
Eccles, D1
Maher, ER1
Bertario, L1
Jarvinen, HJ1
Lindblom, A1
Evans, DG1
Lubinski, J1
Morrison, PJ1
Ho, JW1
Vasen, HF1
Side, L1
Thomas, HJ1
Scott, RJ1
Dunlop, M1
Barker, G1
Elliott, F1
Jass, JR1
Fodde, R1
Lynch, HT1
Mathers, JC1
Zell, JA1
Ziogas, A1
Bernstein, L1
Clarke, CA1
Deapen, D1
Largent, JA1
Neuhausen, SL1
Stram, DO1
Ursin, G1
Anton-Culver, H1
Bousserouel, S1
Gosse, F1
Bouhadjar, M1
Soler, L1
Marescaux, J1
Raul, F1
Vieth, M1
Görgens, D1
Langner, C1
Dibra, HK1
Brown, JE1
Hooley, P1
Nicholl, ID1
Brasky, TM1
Bonner, MR1
Moysich, KB1
Ambrosone, CB1
Nie, J1
Tao, MH1
Edge, SB1
Kallakury, BV1
Marian, C1
Goerlitz, DS1
Trevisan, M1
Shields, PG1
Freudenheim, JL1
Battinelli, EM1
Markens, BA1
Italiano, JE1
Cheng, BQ1
Jiang, Y1
Li, DL1
Fan, JJ1
Ma, M1
Winter, AC1
Rexrode, KM1
Lee, IM1
Buring, JE1
Tamimi, RM1
Kurth, T1
Printz, C1
Serebruany, VL1
Dinicolantonio, JJ1
Can, MM1
Goto, S1
Muscat, JE1
Chen, SQ1
Richie, JP1
Altorki, NK1
Citron, M1
Olson, S1
Neugut, AI1
Stellman, SD1
KINLOCH, JD1
WEBB, JN1
ECCLESTON, D1
ZEITLIN, J1
Asano, TK1
McLeod, RS1
Raskov, HH1
Fisher, GH1
Geronemus, RG1
Ushijima, K1
Yahata, H1
Yoshikawa, H1
Konishi, I1
Yasugi, T1
Saito, T2
Nakanishi, T1
Sasaki, H1
Saji, F1
Iwasaka, T1
Hatae, M1
Kodama, S1
Terakawa, N1
Yaegashi, N1
Hiura, M1
Sakamoto, A1
Tsuda, H1
Fukunaga, M1
Kamura, T1
Scappaticci, FA1
Skillings, JR1
Holden, SN1
Gerber, HP1
Miller, K1
Kabbinavar, F1
Bergsland, E1
Ngai, J1
Holmgren, E1
Wang, J1
Hurwitz, H1
Xin, B1
Yokoyama, Y1
Shigeto, T1
Mizunuma, H1
Sweeting, JG1
Elder, DJ1
Hague, A1
Hicks, DJ1
Paraskeva, C1
Giuliano, F1
Warner, TD1
Krishnan, K1
Ruffin, MT1
Normolle, D1
Shureiqi, I1
Burney, K1
Bailey, J1
Peters-Golden, M1
Rock, CL1
Boland, CR1
Brenner, DE1
Flescher, E1
Rotem, R1
Glaves, D1
Weiss, L1
Spry, LA1
Zenser, TV1
Cohen, SM1
Davis, BB1
Jaffe, BM1
Hegarty, MM1
Grime, RT1
Schofield, PF1
Gasic, GJ1
Gasic, TB1
Galanti, N1
Johnson, T1
Murphy, S1
Moertel, CG1
Ahmann, DL1
Taylor, WF1
Schwartau, N1

Clinical Trials (5)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
ASPIRED: ASPirin Intervention for the REDuction of Colorectal Cancer Risk[NCT02394769]180 participants (Actual)Interventional2015-07-06Active, not recruiting
Value of Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Fertility-preserving Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Carcinoma[NCT03463252]Phase 2/Phase 3224 participants (Anticipated)Interventional2018-04-01Recruiting
A Multicenter, Open-Label, Phase III, Randomized, Active-Controlled Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of rhuMAb VEGF (Bevacizumab), in Combination With Capecitabine Chemotherapy, in Subjects With Previously Treated Metastatic Bre[NCT00109239]Phase 30 participants Interventional2000-11-30Completed
A Phase III, Multicenter, Randomized, Active-Controlled Clinical Trial to Evaluate the Efficacy and Safety of rhuMAb VEGF (Bevacizumab) in Combination With Standard Chemotherapy in Subjects With Metastatic Colorectal Cancer[NCT00109070]Phase 30 participants Interventional2000-09-30Completed
A Phase II, Multicenter, Double-Blind, Randomized, Active-Controlled Clinical Trial to Evaluate the Efficacy and Safety of rhuMAb VEGF (Bevacizumab), a Recombinant Humanized Monoclonal Antibody to Vascular Endothelial Growth Factor, in Combination With 5-[NCT00109226]Phase 20 participants Interventional2000-08-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Change in Urinary Prostaglandin Metabolites (PGE-M)

Measured using liquid chromatography/mass spectrometry (NCT02394769)
Timeframe: 8-12 weeks

,,
Interventionng/mg cr (Mean)
Baseline urinary PGE-MPost-intervention urinary PGE-MChange in urinary PGE-M
Low Dose Aspirin17.713.1-4.6
Placebo (For Aspirin)15.516.40.8
Standard Dose Aspirin14.39.4-4.9

Reviews

6 reviews available for aspirin and Carcinoma, Anaplastic

ArticleYear
[ASA - from cardiovascular to cancer prevention].
    Deutsche medizinische Wochenschrift (1946), 2016, Volume: 141, Issue:5

    Topics: Aspirin; Carcinoma; Cardiovascular Diseases; Drug Therapy, Combination; Female; Humans; Male; Proton

2016
Approach to Lynch Syndrome for the Gastroenterologist.
    Digestive diseases and sciences, 2017, Volume: 62, Issue:2

    Topics: Adenoma; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma; Colectomy; Colonoscopy; Colore

2017
Non steroidal anti-inflammatory drugs (NSAID) and Aspirin for preventing colorectal adenomas and carcinomas.
    The Cochrane database of systematic reviews, 2004, Issue:2

    Topics: Adenoma; Adenomatous Polyposis Coli; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma; Co

2004
[Non-steroidal anti-inflammatory agents and prevention of colorectal adenomas and carcinomas].
    Ugeskrift for laeger, 2006, Jan-23, Volume: 168, Issue:4

    Topics: Adenoma; Adenomatous Polyposis Coli; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents;

2006
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.
    Journal of the National Cancer Institute, 2007, Aug-15, Volume: 99, Issue:16

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Com

2007
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.
    Journal of the National Cancer Institute, 2007, Aug-15, Volume: 99, Issue:16

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Com

2007
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.
    Journal of the National Cancer Institute, 2007, Aug-15, Volume: 99, Issue:16

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Com

2007
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.
    Journal of the National Cancer Institute, 2007, Aug-15, Volume: 99, Issue:16

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Com

2007
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.
    Journal of the National Cancer Institute, 2007, Aug-15, Volume: 99, Issue:16

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Com

2007
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.
    Journal of the National Cancer Institute, 2007, Aug-15, Volume: 99, Issue:16

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Com

2007
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.
    Journal of the National Cancer Institute, 2007, Aug-15, Volume: 99, Issue:16

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Com

2007
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.
    Journal of the National Cancer Institute, 2007, Aug-15, Volume: 99, Issue:16

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Com

2007
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.
    Journal of the National Cancer Institute, 2007, Aug-15, Volume: 99, Issue:16

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Com

2007
Prostaglandins and cancer: an update.
    Prostaglandins, 1974, Jun-25, Volume: 6, Issue:6

    Topics: Animals; Aspirin; Bucladesine; Calcium; Carcinoma; Cell Division; Cell Line; Depression, Chemical; H

1974

Trials

5 trials available for aspirin and Carcinoma, Anaplastic

ArticleYear
ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial.
    Trials, 2017, 02-01, Volume: 18, Issue:1

    Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Anticarcinogenic Agents; Aspirin; Biomarkers, T

2017
Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.
    The New England journal of medicine, 2008, Dec-11, Volume: 359, Issue:24

    Topics: Adenoma; Adult; Aged; Aspirin; Carcinoma; Colorectal Neoplasms; Colorectal Neoplasms, Hereditary Non

2008
Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Jul-01, Volume: 25, Issue:19

    Topics: Adult; Aspirin; Carcinoma; Disease-Free Survival; Endometrial Neoplasms; Endometrium; Female; Fertil

2007
Colonic mucosal prostaglandin E2 and cyclooxygenase expression before and after low aspirin doses in subjects at high risk or at normal risk for colorectal cancer.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2001, Volume: 10, Issue:5

    Topics: Adult; Aged; Analysis of Variance; Aspirin; Biomarkers, Tumor; Biopsy, Needle; Carcinoma; Colorectal

2001
Aspirin and pancreatic cancer pain.
    Gastroenterology, 1971, Volume: 60, Issue:4

    Topics: Adenocarcinoma; Aspirin; Carcinoma; Codeine; Colonic Neoplasms; Humans; Pancreatic Neoplasms; Placeb

1971

Other Studies

34 other studies available for aspirin and Carcinoma, Anaplastic

ArticleYear
Low-dose aspirin and incidence of lung carcinoma in patients with chronic obstructive pulmonary disease in Hong Kong: A cohort study.
    PLoS medicine, 2022, Volume: 19, Issue:1

    Topics: Aged; Aged, 80 and over; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma; Cohor

2022
Risk factors for the occurrence of ampullary tumors: A case-control study.
    United European gastroenterology journal, 2022, Volume: 10, Issue:7

    Topics: Adenoma; Ampulla of Vater; Aspirin; Carcinoma; Case-Control Studies; Common Bile Duct Neoplasms; Duo

2022
Antiplatelet agents aspirin and dipyridamole, and the risk of different carcinoma in patients with type 2 diabetes mellitus: A Taiwan retrospective cohort study.
    Medicine, 2022, Sep-16, Volume: 101, Issue:37

    Topics: Aspirin; Carcinoma; Diabetes Mellitus, Type 2; Dipyridamole; Humans; Liver Neoplasms; Platelet Aggre

2022
Head-to-Head Comparison of the Performance of 17 Risk Models for Predicting Presence of Advanced Neoplasms in Colorectal Cancer Screening.
    The American journal of gastroenterology, 2019, Volume: 114, Issue:9

    Topics: Adenoma; Age Factors; Aged; Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Area Under Cu

2019
Postdiagnosis Aspirin Use Associated With Decreased Biliary Tract Cancer-Specific Mortality in a Large Nationwide Cohort.
    Hepatology (Baltimore, Md.), 2021, Volume: 74, Issue:4

    Topics: Aged; Aged, 80 and over; Ampulla of Vater; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bile Du

2021
Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study.
    Hepatology (Baltimore, Md.), 2021, Volume: 74, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bile Duct Neoplasms; Bile

2021
The impact of aspirin use on colorectal cancer patients.
    European journal of cancer (Oxford, England : 1990), 2013, Volume: 49, Issue:9

    Topics: Aspirin; Carcinoma; Colorectal Neoplasms; Female; Humans; Male

2013
Response to letter commenting on paper EJC-D-12-01401: Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality.
    European journal of cancer (Oxford, England : 1990), 2013, Volume: 49, Issue:9

    Topics: Aspirin; Carcinoma; Colorectal Neoplasms; Female; Humans; Male

2013
The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection.
    BMC gastroenterology, 2013, Sep-06, Volume: 13

    Topics: Adenoma; Aged; Anti-Ulcer Agents; Anticoagulants; Aspirin; Carcinoma; Case-Control Studies; Clopidog

2013
Regular aspirin use and nasopharyngeal cancer risk: A case-control study in Italy.
    Cancer epidemiology, 2015, Volume: 39, Issue:4

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma; Case-Control Studies; Fema

2015
Protective Effect of Aspirin Against Oligomeric Aβ42 Induced Mitochondrial Alterations and Neurotoxicity in Differentiated EC P19 Neuronal Cells.
    Current Alzheimer research, 2017, Volume: 14, Issue:8

    Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; Apoptosis; Aspirin; Carcinoma; Cell Differenti

2017
Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis.
    Cancer, 2009, Dec-15, Volume: 115, Issue:24

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma; Colorectal Neoplasms; Female; Fol

2009
Long-term administration of aspirin inhibits tumour formation and triggers anti-neoplastic molecular changes in a pre-clinical model of colon carcinogenesis.
    Oncology reports, 2010, Volume: 23, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Azoxymethane; Carc

2010
[Pseudoneoplastic regeneration of the stomach. Histopathology and differential diagnosis].
    Der Pathologe, 2010, Volume: 31, Issue:3

    Topics: Aspirin; Carcinoma; Diagnosis, Differential; Gastritis; Helicobacter Infections; Humans; Intestinal

2010
Aspirin and alterations in DNA repair proteins in the SW480 colorectal cancer cell line.
    Oncology reports, 2010, Volume: 24, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma; Cell Line, Tumor; Cell Survival; Colore

2010
Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype.
    Cancer causes & control : CCC, 2011, Volume: 22, Issue:7

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers, Tumor; Breast Neoplasms;

2011
Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis.
    Blood, 2011, Aug-04, Volume: 118, Issue:5

    Topics: Adenosine Diphosphate; Angiogenesis Modulating Agents; Aspirin; Blood Platelets; Breast Neoplasms; C

2011
Up-regulation of thy-1 promotes invasion and metastasis of hepatocarcinomas.
    Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:4

    Topics: alpha-Fetoproteins; Analysis of Variance; Aspirin; Cadherins; Carcinoma; Cell Differentiation; Chi-S

2012
Migraine and subsequent risk of breast cancer: a prospective cohort study.
    Cancer causes & control : CCC, 2013, Volume: 24, Issue:1

    Topics: Aged; Aged, 80 and over; Aspirin; Breast Neoplasms; Carcinoma; Chemoprevention; Cohort Studies; Doub

2013
Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality.
    European journal of cancer (Oxford, England : 1990), 2013, Volume: 49, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma; Cause o

2013
Aspirin extends life of some patients with colorectal cancer.
    Cancer, 2013, Feb-01, Volume: 119, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma; Class I Phosphatidylinositol 3-Kinases;

2013
Unclassified pleomorphic and spindle cell pulmonary neoplasm with brain metastases after prasugrel.
    Cardiology, 2013, Volume: 124, Issue:2

    Topics: Aged; Aspirin; Brain Neoplasms; Carcinoma; Clinical Trials, Phase III as Topic; Clopidogrel; Colonic

2013
Risk of lung carcinoma among users of nonsteroidal antiinflammatory drugs.
    Cancer, 2003, Apr-01, Volume: 97, Issue:7

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma; Case-Control Studies; Female; Hum

2003
CARCINOID SYNDROME ASSOCIATED WITH OAT-CELL CARCINOMA OF BRONCHUS.
    British medical journal, 1965, Jun-12, Volume: 1, Issue:5449

    Topics: Aprotinin; Aspirin; Avena; Bronchi; Bronchial Neoplasms; Carcinoma; Chlorpromazine; Drug Therapy; En

1965
Treatment of multiple familial trichoepitheliomas with a combination of aspirin and a neutralizing antibody to tumor necrosis factor alpha: A case report and hypothesis of mechanism.
    Archives of dermatology, 2006, Volume: 142, Issue:6

    Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aspirin; Carcinoma; Di

2006
Anti-tumor effect of non-steroidal anti-inflammatory drugs on human ovarian cancers.
    Pathology oncology research : POR, 2007, Volume: 13, Issue:4

    Topics: Animals; Aspirin; Carcinoma; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Humans;

2007
Aspirin versus colonoscopy in the reduction of carcinoma of the colon.
    Gastroenterology, 1995, Volume: 108, Issue:2

    Topics: Adult; Aged; Aspirin; Carcinoma; Cohort Studies; Colonic Neoplasms; Colonoscopy; Humans; Male; Middl

1995
Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma relative to adenoma cell lines.
    Cancer research, 1996, May-15, Volume: 56, Issue:10

    Topics: 3T3 Cells; Adenoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Carcinoma;

1996
Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs.
    British journal of pharmacology, 1999, Volume: 126, Issue:8

    Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Blood Pressu

1999
Protein kinase C epsilon mediates the induction of P-glycoprotein in LNCaP prostate carcinoma cells.
    Cellular signalling, 2002, Volume: 14, Issue:1

    Topics: Aspirin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma; Diterpenes; Enzyme Inhi

2002
Initial tumor cell arrest in animals of defined coagulative status.
    International journal of cancer, 1978, Jun-15, Volume: 21, Issue:6

    Topics: Animals; Anticoagulants; Aspirin; Blood Coagulation; Carcinoma; Heparin; Lymphoma, Non-Hodgkin; Mice

1978
Role of renal metabolism and excretion in 5-nitrofuran-induced uroepithelial cancer in the rat.
    The Journal of clinical investigation, 1985, Volume: 76, Issue:3

    Topics: Administration, Oral; Animals; Aspirin; Carcinoma; FANFT; Glomerular Filtration Rate; In Vitro Techn

1985
The management of upper gastro-intestinal tract haemorrhage.
    The British journal of surgery, 1973, Volume: 60, Issue:4

    Topics: Adolescent; Adult; Aged; Aortic Aneurysm; Aspirin; Carcinoma; Duodenal Ulcer; Esophageal and Gastric

1973
Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease.
    International journal of cancer, 1973, Volume: 11, Issue:3

    Topics: Adenocarcinoma; Animals; Aspirin; Blood Cell Count; Blood Platelets; Carcinoma; Cell Survival; Chrom

1973